Samuel Deadwyler to Benzoxazines
This is a "connection" page, showing publications Samuel Deadwyler has written about Benzoxazines.
Connection Strength
0.394
-
Hampson RE, Sweatt AJ, Goonawardena AV, Song D, Chan RH, Marmarelis VZ, Berger TW, Deadwyler SA. Memory encoding in hippocampal ensembles is negatively influenced by cannabinoid CB1 receptors. Behav Pharmacol. 2011 Aug; 22(4):335-46.
Score: 0.088
-
Hampson RE, Miller F, Palchik G, Deadwyler SA. Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity. Neuropharmacology. 2011 May; 60(6):944-52.
Score: 0.085
-
Deadwyler SA, Goonawardena AV, Hampson RE. Short-term memory is modulated by the spontaneous release of endocannabinoids: evidence from hippocampal population codes. Behav Pharmacol. 2007 Sep; 18(5-6):571-80.
Score: 0.067
-
Zhuang SY, Bridges D, Grigorenko E, McCloud S, Boon A, Hampson RE, Deadwyler SA. Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores. Neuropharmacology. 2005 Jun; 48(8):1086-96.
Score: 0.057
-
Hampson RE, Zhuang SY, Weiner JL, Deadwyler SA. Functional significance of cannabinoid-mediated, depolarization-induced suppression of inhibition (DSI) in the hippocampus. J Neurophysiol. 2003 Jul; 90(1):55-64.
Score: 0.049
-
Hampson RE, Simeral JD, Kelly EJ, Deadwyler SA. Tolerance to the memory disruptive effects of cannabinoids involves adaptation by hippocampal neurons. Hippocampus. 2003; 13(5):543-56.
Score: 0.048